Endometrial assessment for fertility-sparing treatment of young women with early-stage endometrial carcinoma: adaptation of a standardized synoptic reporting
Authors:
- 24 June 2025
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 487 (6) , 1401-1406
Abstract
Recent guidelines emphasize regular endometrial assessment for fertility-sparing treatment (FST) in endometrial carcinoma (EC), but no consensus exists on histological reporting. We reviewed 14 patients under 40 years old with early-stage, low-grade endometrial endometrioid carcinoma (EEC) treated with FST. Our patients received oral therapy (28.6%) or combined oral therapy with intrauterine device (71.4%), and were followed for 11-76 months (median, 31.5 months). Using a classification proposed by Wheeler et al., treatment outcomes included resolution (50%), persistence (14.3%), progression (14.3%), and recurrence (21.4%). Resolution occurred within 4-15 months. Two patients achieved successful pregnancies. Three underwent hysterectomy, including one with progression and distant metastasis. We find that young women with EEC often extend FST beyond recommended durations due to strong fertility desires, increasing progression risk. Standardized synoptic reporting with routine reviews of prior biopsies, obtaining deeper tissue sections, and seeking second opinions can improve endometrial assessment and guide treatment.Keywords
This publication has 13 references indexed in Scilit:
- Fertility‐Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic ReviewBioMed Research International, 2022
- Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future DirectionsInternational Journal of Molecular Sciences, 2022
- Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid CarcinomaInternational Journal of Gynecological Pathology, 2021
- Molecular classification defines outcomes and opportunities in young women with endometrial carcinomaGynecologic Oncology, 2019
- Endocrine therapy in endometrial cancer: An old dog with new tricksGynecologic Oncology, 2019
- Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic reviewActa Obstetricia et Gynecologica Scandinavica, 2019
- Assessing Endometrial Hyperplasia and Carcinoma Treated With Progestin TherapyAmerican Journal of Clinical Pathology, 2012
- Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic reviewGynecologic Oncology, 2012
- Histologic Alterations in Endometrial Hyperplasia and Well-differentiated Carcinoma Treated With ProgestinsAmerican Journal of Surgical Pathology, 2007
- The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphologyJournal of Clinical Pathology, 2003